Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber

被引:10
作者
Gherasim, Alina [1 ]
Fauquert, Jean-Luc [2 ]
Domis, Nathalie [1 ]
Siomboing, Xavier [3 ]
de Blay, Frederic [1 ,4 ,5 ]
机构
[1] ALYATEC Environm Exposure Chamber, 1 Pl Hop, F-67000 Strasbourg, France
[2] Univ Hosp, Clermont Ferrand, France
[3] Soladis Clin Studies, Roubaix, France
[4] Strasbourg Univ Hosp, Chest Dis Dept, Strasbourg, France
[5] Univ Strasbourg, Strasbourg, France
关键词
birch allergy; conjunctival allergen challenge; conjunctivitis; environmental exposure chamber; POLLEN; RHINITIS; IMMUNOTHERAPY; DURATION; ASTHMA; ONSET; TESTS;
D O I
10.1002/clt2.12053
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Environmental exposure chambers (EECs) have been used extensively to study allergic rhinoconjunctivitis. Few studies have been published using EECs in conjunctivitis only, and none have used conjunctival allergen challenge as a selection criterion. The present study validated ALYATEC EEC in allergic conjunctivitis to birch pollen. Methods Sixteen patients with a positive conjunctival allergen challenge (CAC) were exposed to 60 ng/m(3) of Bet v 1 in an EEC on two consecutive days for a maximum of 4 h to validate EEC exposure to birch. Reproducibility was tested among seven of the patients. A conjunctival positive scoring during the CAC and the EEC exposure was defined as a Total Ocular Symptom Score (TOSS) >= 5. Results Fifty percent of patients had a conjunctival positive scoring during first exposure and 75% during second exposure. The mean time to a conjunctival response was 81.2 +/- 33.9 min and 101.6 +/- 57 (P > 0.05) during first and second exposure, respectively. No difference in TOSS occurred between the two exposures. The time necessary to obtain a positive response during the CAC was significantly shorter than with the EEC. The estimated quantity of Bet v 1 inducing a positive response was 0.07 +/- 0.03 ng (exposure 1), 0.07 +/- 0.07 ng (exposure 2), 980 +/- 784 ng (CAC). Conjunctival positive scoring and quantity of Bet v 1 was reproducible in all six EEC exposures. Conclusions Early conjunctival responses induced by birch allergen exposures in EEC were different than from those identified with direct instillation during CAC. EEC appears to be closer to natural exposure than CAC.
引用
收藏
页数:9
相关论文
共 39 条
[31]   Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge [J].
Lanier, BQ ;
Abelson, MB ;
Berger, WE ;
Granet, DB ;
D'Arienzo, PA ;
Spangler, DL ;
Kagi, MK .
CLINICAL THERAPEUTICS, 2002, 24 (07) :1161-1174
[32]   Clinical symptoms and biomarkers of Bermuda grass-induced allergic rhinitis using the nasal allergen challenge model [J].
Rawls, Matthew ;
Thiele, Jenny ;
Adams, Daniel E. ;
Steacy, Lisa M. ;
Ellis, Anne K. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (06) :608-+
[33]   Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model [J].
Abelson, MB ;
Greiner, JV .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) :1953-1958
[34]   Exposure chamber for allergen challenge. A placebo-controlled, double-blind trial in house-dust-mite asthma [J].
Ronborg, SM ;
Mosbech, H ;
Poulsen, LK .
ALLERGY, 1997, 52 (08) :821-828
[35]   Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: Early evidence supporting a paradigm shift in drug investigation? [J].
Bernstein, Jonathan A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 130 (01) :128-129
[36]   Targeted Micronutrient Supplementation with holo-BLG based on the Farm Effect in Patients with House Dust Mite-induced Allergic Rhinitis - first Evaluation in an Allergen Exposure Chamber [J].
Bergmann, Karl-Christian ;
Graessel, Anke ;
Raab, Jennifer ;
Banghard, Werner ;
Krause, Linda ;
Becker, Sylvia ;
Kugler, Sebastian ;
Zuberbier, Torsten ;
Ott, Verena B. ;
Kramer, Matthias F. ;
Roth-Walter, Franziska ;
Jensen-Jarolim, Erika ;
Guethoff, Sonja .
ALLERGO JOURNAL, 2021, 30 (04) :50-61
[37]   Time to Onset and Duration of Action of the Antihistamine Bepotastine Besilate Ophthalmic Solutions 1.0% and 1.5% in Allergic Conjunctivitis: A Phase III, Single-Center, Prospective, Randomized, Double-Masked, Placebo-Controlled, Conjunctival Allergen Challenge Assessment in Adults and Children [J].
Abelson, Mark B. ;
Torkildsen, Gail L. ;
Williams, Jon I. ;
Gow, James A. ;
Gomes, Paul J. ;
McNamara, Timothy R. .
CLINICAL THERAPEUTICS, 2009, 31 (09) :1908-1921
[38]   Efficacy of air cleaners to reduce allergic responses to cat: A randomized clinical trial using an environmental exposure chamber [J].
Gherasim, Alina ;
Dietsch, Frank ;
Odul, Florian ;
Riff, Thibaut ;
Domis, Nathalie ;
de Blay, Frederic .
RESPIRATORY MEDICINE, 2025, 242
[39]   Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models [J].
Spangler, DL ;
Abelson, MB ;
Ober, A ;
Gomes, PJ .
CLINICAL THERAPEUTICS, 2003, 25 (08) :2245-2267